CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.70060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Yueqi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, RNA, Circular, Immunotherapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation of Science and Technology Committee of Shanghai Municipality, Clinical Research Project and Outstanding Backbone Scheme of Zhongshan Hospital.
Abstract (Originalsprache)
Circular RNAs (circRNAs) have been shown to play important roles in tumour development and tumour immunology. However, genome‐wide characterisation of circRNAs and their roles in the immunology and immunotherapy of gallbladder carcinoma (GBC) has been lacking. We present a comprehensive characterisation of the circRNA landscape in GBC, revealing GBC‐specific circRNAs. Our analysis found that circRNAs are significantly enriched in cell proliferation and are involved in cancer‐related hallmarks. In particular, circAATF was upregulated in GBC, which was positively correlated with AATF mRNA expression, and promoted GBC cell growth. Through integrating computational and experimental approaches, we revealed that circAATF is positively associated with the CD4 + T cell abundance and PD‐L1 level, and enhances the clinical benefits of anti‐PD‐L1 immunotherapy for GBC. We further demonstrate that circAATF elevates the PD‐L1 level by activating phosphorylated AKT and acting as a sponge for miR‐142‐5p. CircAATF is positively associated with CD4 + T cells and PD‐L1 levels and shows potential to aid anti‐PD‐L1 immunotherapy for GBC. Our study provides insights into roles of circAATF in the tumour development and immunology of GBC and accelerates the development of therapeutic strategies for GBC immunotherapy. Highlights We present a comprehensive characterisation of circRNA landscape in gallbladder carcinoma (GBC). CircAATF is positively associated with CD4 + T cell abundance and PD‐L1 expression and is shown to promote PD‐L1 treatment in mouse model. CircAATF can elevate PD‐L1 level through phosphorylated AKT and linear AATF, which upregulates PD‐L1 by acting as a sponge of miR‐142‐5p.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biliary Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
- Biliary Tract Diseases Institute, Fudan University, Shanghai, China.
- Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
- Precision Research Center for Refractory Diseases and Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Compound Chinese Medicines, The MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai,…
- Department of General Surgery, Xuhui District Central Hospital of Shanghai, Shanghai, China.
ORCID-Profile: Shengli Li, Lingxi Nan
Förderung
- National Natural Science Foundation of China
- Foundation of Science and Technology Committee of Shanghai Municipality
- Clinical Research Project and Outstanding Backbone Scheme of Zhongshan Hospital
- Shanghai Pujiang Program
Zitieren
APA
Wang, Y., Li, S., Bo, X., Li, Y., Wang, C., Nan, L., Zhang, D., Liu, H., & Zhang, J. (2024). CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70060
Vancouver
Wang Y, Li S, Bo X, Li Y, Wang C, Nan L, et al. CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.70060
BibTeX
@article{Wang2024,
author = {Wang, Yueqi and Li, Shengli and Bo, Xiaobo and Li, Yuan and Wang, Changcheng and Nan, Lingxi and Zhang, Dexiang and Liu, Houbao and Zhang, Jiwei},
title = {CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.70060}
}
EUVIMED